Modern Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
79,117
+15,933
+25% +$417K 0.02% 399
2026
Q1
$1.8M Buy
63,184
+17,665
+39% +$470K 0.03% 320
2025
Q4
$1.13M Sell
45,519
-2,732
-6% -$68.9K 0.02% 389
2025
Q3
$1.23M Sell
48,251
-754
-2% -$18.6K 0.02% 350
2025
Q2
$1.19M Buy
49,005
+4,220
+9% +$98.4K 0.03% 336
2025
Q1
$1.13M Buy
44,785
+13,104
+41% +$343K 0.04% 289
2024
Q4
$840K Buy
31,681
+3,803
+14% +$103K 0.03% 281
2024
Q3
$807K Buy
27,878
+9,074
+48% +$265K 0.05% 189
2024
Q2
$526K Buy
18,804
+909
+5% +$25K 0.04% 211
2024
Q1
$497K Buy
17,895
+10,242
+134% +$284K 0.05% 172
2023
Q4
$220K Buy
+7,653
New +$231K 0.03% 177

Other funds holding PFE

Modern Wealth Management's PFE Position: Q2 2026 in Review

Modern Wealth Management increased its Pfizer (PFE) stake by 25% in Q2 2026, buying an estimated $417K and bringing the position to 79,117 shares worth $1.91M. The position accounts for 0.02% of the portfolio, ranked #399.

Modern Wealth Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Modern Wealth Management held 79,117 shares of Pfizer worth $1.91M as of Q2 2026.
  • Modern Wealth Management bought 15,933 Pfizer shares in Q2 2026, an estimated $417K.
  • Pfizer made up 0.02% of Modern Wealth Management's portfolio in Q2 2026, its #399 holding.
  • Modern Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.